Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

What’s in a number? Estimating the cost of cybercrime

If you need to understand property crime in the US, visit the Federal Bureau of Investigation’s website. Its Uniform Crime Report will tell you how many offenses were committed nationally in 2011 (9,063,173) and of what type (burglary 24%, larceny 68% and motor vehicle theft 7.9%). It will also give you an estimate of how much property crime cost the US economy that year ($15.6bn).

Strategies for seasonal influenza

Research Methodology

This report draws on two main sources for its research and findings:

In June 2013, The Economist Intelligence Unit surveyed 418 senior business executives from the US, the UK, Germany, France, Italy and Spain—one-half of whom are from the board or C-level (CEO, CFO, CIO, etc). Twenty industries are represented in this sample, with just over one-quarter (28%) of companies coming from financial services or manufacturing. Around one-half of these companies have more than 500 employees or more than US$500m in annual revenue.

Lessons on collaboration from North Karelia

One of the best known population-level prevention programmes took place in the North Karelia region of Finland: around 40 years ago the area’s population suffered from very high rates of non-communicable disease (NCD), even compared to Finland’s very high levels of the time.

The challenge of speed in healthcare

The healthcare sector needs to change faster. There is pressure to improve existing administrative processes and interoperability between systems, while at the same time increasing the awareness of patients and the skills of healthcare professionals. How else can the sector modernise quickly enough to deliver the preventive medicines and personal health support required to meet the growing demand? 

Innovation in life sciences

The life sciences sector is capital-intensive, risky, and highly regulated. It is little surprise to find that innovation is dominated by large incumbent firms from Western markets. However, it is possible for emerging markets to become life sciences innovators.  Emerging markets have gained ground over the past three decades, becoming innovators in their own right. India, China, Brazil, South Korea, Costa Rica and Singapore all found a life sciences niche in a relatively short space of time in areas such as biologics, medical technology and health informatics.

Innovation in life sciences

This report, commissioned by Dubai Science Park, traces their trajectories from imitators to innovators, explores the obstacles faced, and identifies strategic lessons for countries seeking to nurture their own life sciences sector.

Speed and quality under pressure: How financial services are different

As technology changes, financial services organisations ought to be ripe for innovation.

Sub-Saharan African healthcare

Research Methodology

Fortune favors the brave

On the front page of its June 2012 edition, the Chinese journal Health News published a poem by Chen Zhu, the minister of health. It read, in part, “The wind and thunder moving health reform across the country herald glad tidings/.../The deep pool is nothing to be afraid of…Heroes dare to cross.” Unorthodox though it was for a strategy memo, it turns out that this call to action may contain good advice for companies.

Health care reform and life sciences

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week